Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jaume Pons Insider Profile
11 Followers
Jaume Pons, PRESIDENT & CSO at ALX Oncology Holdings, holds 580.71K shares in ALX Oncology Holdings (Ticker: ALXO). Most recently, Jaume Pons Sold $10,796 shares of ALX Oncology Holdings on Jan 02, 2025 for an estimated value of 17.06K.
Jaume Pons ALX Oncology Holdings (ALXO)PRESIDENT & CSO
ALX Oncology Holdings (ALXO)
PRESIDENT & CSO
Ranked #19,493 out of 100,285 Corporate Insiders
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+16.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
PRESIDENT & CSO
Roles that Jaume Pons holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jaume Pons
Jaume Pons's Trading History
List of latest transactions for each holding click on a transaction to see Jaume Pons's performance on stock
You May Also Like
Jaume Pons insider profile FAQ
What is the percentage of profitable transactions made by Jaume Pons?
The percentage of profitable transactions made by Jaume Pons is 60%.
What is the average return per transaction made by Jaume Pons?
The average return per transaction made by Jaume Pons is 16.40%.
What stocks does Jaume Pons hold?
Jaume Pons holds: ALXO stocks.
What was Jaume Pons’s latest transaction?
Jaume Pons latest transaction was an Informative Sell of $17.06K.
What was Jaume Pons's most profitable transaction?
Jaume Pons’s most profitable transaction was an Informative Sell of ALXO stock on July 3, 2024. The return on the trade was 68.30%.
What is Jaume Pons's role in ALX Oncology Holdings?
Jaume Pons's role in ALX Oncology Holdings is PRESIDENT & CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.